Riskpilot← Back to searchSign inGet full accessAESTMED AS
ASActiveOrg 917285322Oscars Gate 35A, 0258 OsloComputer consultancy and computer facilities management activities · NACE 6220Est. 20161 employees
Revenue 2024
NOK 1,7M
+78% vs 2023
EBITDA margin
13.6%
+208% vs 2023
Equity ratio
56.0%
Financial strength
Net profit 2024
NOK 197K
+190% vs 2023
| Revenue | NOK 1,7M | +78% |
| EBITDA | NOK 228K | +208% |
| Net profit | NOK 197K | +190% |
| Total assets | NOK 825K | +67% |
| Equity | NOK 462K | +42% |
| Employees | 1 | — |
Legal name
AESTMED AS
Org number
917285322
Legal form
Aksjeselskap
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
9. juni 2016
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utvikle, selge og vedlikeholde ikt tjenester og serviceløsninger, samt rådgivning for medisinsk virksomhet og andre tjenesteytende virksomheter, herunder deltagelse i andre selskap.
Address
Oscars Gate 35A, 0258 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 662 | 846 | 889 | 939 | 1 671 |
| Staff expenses | −0 | −0 | −10 | −698 | −956 |
| EBITDA | 270 | 33 | 242 | −210 | 228 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 270 | 33 | 242 | −210 | 228 |
| Net financials | −0 | 1 | 0 | −9 | −1 |
| Profit before tax | 270 | 33 | 242 | −219 | 227 |
| Tax | 61 | 20 | 53 | −0 | 30 |
| Net profit | 209 | 13 | 189 | −219 | 197 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 549 | 434 | 666 | 493 | 825 |
| Equity | 342 | 355 | 544 | 325 | 462 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 207 | 78 | 122 | 168 | 363 |
| Total debt | 207 | 78 | 122 | 168 | 363 |
EBITDA margin
13.6%
This company
15.8%
Market median
-14% vs market
20202024
Equity ratio
56.0%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
42.7%
This company
18.4%
Market median
+132% vs market
20202024
Net profit margin
11.8%
This company
8.1%
Market median
+46% vs market
20202024
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RA Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 27.9% | 27.9% | 2022 | |
| Company | 27.9% | 27.9% | 2022 | |
| Company | 16.3% | 16.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Convent Capital As
AESTMED AS Board members of AESTMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ramon Andres Espinosa Gutierrez | Chief Executive Officer | 0 companies |
| Mads Henrik Langaard Lund | Board of Directors | 0 companies |
| Christian Oudenstad Søhoel | Board of Directors | 0 companies |
| Krenar Badivuku | Chairman | 0 companies |
| Claes Stephan Truedsson | Chairman | 0 companies |
| William Andree Høvik | Board of Directors | 0 companies |